Beta-lactam antibiotic dosing during continuous renal replacement therapy: how can we optimize therapy?

Area of Science:

• Pharmacology
• Nephrology
• Critical Care Medicine

Background:

• Antibiotic dosing in critically ill patients is complex due to physiological changes like shock and organ dysfunction.
• Hydrophilic antibiotic pharmacokinetics are significantly impacted by these patient-specific factors.
• Extracorporeal circuits, particularly continuous renal replacement therapy (CRRT), add further complexity to antibiotic management.

Purpose of the Study:

• To highlight the challenges in determining optimal antibiotic dosing for critically ill patients undergoing CRRT.
• To discuss the impact of pathophysiology and CRRT on antibiotic pharmacokinetics.
• To review current understanding and suggest a pragmatic approach to antibiotic dosing in this population.

Main Methods:

• Review of existing literature on antibiotic pharmacokinetics in critically ill patients.
• Analysis of factors influencing drug concentrations during CRRT.
• Synthesis of findings to propose a dosing strategy.

Main Results:

• Physiological derangements and CRRT significantly alter antibiotic concentrations, leading to potential sub-therapeutic levels or toxicity.
• Variability in CRRT techniques contributes to inconsistent drug concentrations.
• Current data is insufficient for definitive, robust dosing guidelines.

Conclusions:

• Standard antibiotic dosing during the initial 1-2 days of CRRT, followed by dose reduction, appears to be a cautious approach.
• Further well-designed clinical studies are essential to establish evidence-based dosing recommendations for antibiotics during CRRT.
• Individualized dosing adjustments based on pharmacokinetic monitoring are ultimately needed for optimal patient outcomes.